CHISARI, CLARA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 2.937
AS - Asia 1.698
EU - Europa 1.425
SA - Sud America 314
AF - Africa 288
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 6.667
Nazione #
US - Stati Uniti d'America 2.847
SG - Singapore 837
CN - Cina 597
IT - Italia 548
IE - Irlanda 335
BR - Brasile 286
CI - Costa d'Avorio 202
RU - Federazione Russa 170
UA - Ucraina 115
KR - Corea 91
CA - Canada 77
DE - Germania 64
SN - Senegal 62
IN - India 41
GB - Regno Unito 38
VN - Vietnam 33
FR - Francia 28
FI - Finlandia 23
NL - Olanda 23
SE - Svezia 21
TR - Turchia 17
PL - Polonia 14
CH - Svizzera 13
JP - Giappone 12
UZ - Uzbekistan 12
BD - Bangladesh 10
MX - Messico 10
VE - Venezuela 9
HK - Hong Kong 8
PK - Pakistan 8
ZA - Sudafrica 8
AE - Emirati Arabi Uniti 7
AR - Argentina 7
AT - Austria 6
CZ - Repubblica Ceca 6
NG - Nigeria 6
IQ - Iraq 5
BG - Bulgaria 4
EC - Ecuador 4
GR - Grecia 4
KE - Kenya 4
NP - Nepal 4
PE - Perù 4
AZ - Azerbaigian 3
ES - Italia 3
SA - Arabia Saudita 3
AU - Australia 2
BE - Belgio 2
EU - Europa 2
JO - Giordania 2
LB - Libano 2
MA - Marocco 2
PY - Paraguay 2
TN - Tunisia 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
CL - Cile 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
HR - Croazia 1
ID - Indonesia 1
IM - Isola di Man 1
IR - Iran 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NO - Norvegia 1
OM - Oman 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.667
Città #
Santa Clara 668
Singapore 521
Chandler 445
Dublin 327
Chicago 221
Hefei 208
Abidjan 201
Catania 161
Boardman 138
Ashburn 119
Jacksonville 105
Civitanova Marche 90
Seoul 89
Cambridge 80
Lawrence 79
Andover 76
Beijing 63
Dakar 62
Nanjing 60
Saint Petersburg 60
Toronto 49
Des Moines 48
Council Bluffs 39
Bremen 32
Los Angeles 29
São Paulo 29
Dong Ket 26
Wilmington 24
Milan 20
San Francisco 18
Columbus 17
Nanchang 17
Shenyang 17
The Dalles 16
Rome 15
Hebei 13
Belo Horizonte 12
Munich 12
Lappeenranta 11
Ottawa 11
Redwood City 11
Rio de Janeiro 11
Seattle 11
Bernareggio 10
Houston 10
Kiev 10
San Mateo 10
Tokyo 10
Warsaw 10
Naples 9
New York 9
Palermo 9
Giarre 8
Moscow 8
Mumbai 8
Rende 8
Abu Dhabi 7
Amsterdam 7
Helsinki 7
Hong Kong 7
Istanbul 7
Pune 7
Tianjin 7
Brooklyn 6
Dallas 6
Genoa 6
Guangzhou 6
Manchester 6
Padova 6
Salvador 6
Abuja 5
Boston 5
Brasília 5
Changsha 5
Charlotte 5
Chennai 5
Jiaxing 5
Jinan 5
Johannesburg 5
Kunming 5
London 5
Messina 5
Mexico City 5
Porto Alegre 5
Pozzallo 5
St Louis 5
Strasbourg 5
Turku 5
Vicenza 5
Washington 5
Zhengzhou 5
Bari 4
Brno 4
Civitavecchia 4
Edinburgh 4
Goiânia 4
Hanoi 4
Irpin 4
Phoenix 4
Shanghai 4
Totale 4.612
Nome #
The ocular ecosystem in the discoid lupus erythematosus 196
After the sweet comes the bitter. Time to halt the diabetic neuropathy epidemic 108
Aging eye microbiota in dry eye syndrome in patients treated with enterococcus faecium and saccharomyces boulardii 102
Amyotrophic lateral sclerosis: differential diagnosis with cervical myeloradiculopathy 100
Microbiological Etiology of Chronic skin lesions in type 2 Diabetic Subjects 90
Functional stress and microbiota eye in subjects with type 2 diabetes: a multifactorial approach 88
Clinical bacteriological aspects of the Human Amniotic Membrane in the diabetic foot. A case report 84
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience 84
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) 83
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort 81
Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: A randomized clinical trial 79
Amniotic membrane use in type 2 diabetes patients with chronic ulcers: Microbiological evaluation and therapeutic benefits 78
Functional Neurological disorders; those bizarre and painfull disconnections between brain and body 78
CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset 78
Lack of association between Toxocara canis and multiple sclerosis: A population-based case-control study 78
Retinal Thickness and Microvascular Pattern in Early Parkinson's Disease 78
Cancer risk assessment in multiple sclerosis patients in the Eastern Sicily 77
Prevalence and Incidence of Multiple Sclerosis in the City of Biancavilla 76
Migraine causes retinal and choroidal structural changes: evaluation with ocular coherence tomography 74
Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experience 74
An update on the safety of treating relapsing-remitting multiple sclerosis 73
An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management 72
A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmartâ ¢â the FUTURE study 70
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 70
Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod 69
Are oligoclonal bands associated to lower retinal layer thickness at the time of relapsing remitting multiple sclerosis diagnosis? Evidence from an exploratory study 69
Etiology of chronic skin lesions in subjects with peripheral arterial disease 69
Esposizione ad elementi in tracce in aree ad alta incidenza di sclerosi multipla: un ruolo delle ceneri vulcaniche? 67
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 67
Risk factors for ocular surface disorders in patients with type 2 diabetes 66
Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab 66
Clinical-Instrumental patterns of neurodegeneration in Essential Tremor: A data-driven approach 66
Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study) 65
Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study 65
Administration of subcutaneous interferon beta 1a in the evening: data from RELIEF study 65
The ocular surface in patients video display terminal (VDT) 65
Effects of Nintendo Wii Fit® balance exercise program on physical abilities and quality of life in Multiple Sclerosis patients 64
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature 63
Multiple Sclerosis in the Mount Etna region: possible role of volcanogenic trace elements 63
The clinical value of Coop/Wonca charts in assessment of HRQoL in a large cohort of relapsing-remitting multiple sclerosis patients: Results of a multicenter study 63
Inpatient versus outpatient rehabilitation for multiple sclerosis patients: effects on disability and quality of life 63
eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54 63
A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome' 61
The effects of blood glucose regulation onn the microbiota ocular in Type II diabetic subjects 61
Microbiological characteristics of the ocular surface in the patients with discoid lupus erythematosus. 60
Static postural control disturbances among the different multiple sclerosis phenotypes: A Neurocom Balance Manager®evaluation study 59
An update on the pharmacological management of pain in patients with multiple sclerosis 59
Palliative care in multiple sclerosis 58
Retinal Nerve Fiber Layer Thickness and Higher Relapse Frequency May Predict Poor Recovery after Optic Neuritis in MS Patients 58
Toxoplasma gondii and multiple sclerosis: a population-based case–control study 58
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis 58
Early-Onset Alcohol Dependence and Multiple Sclerosis: Diagnostic Challenges 58
Abnormal Eye Movements due to Disease of the Extraocular Muscles and Their Innervation 57
A model-based study of internuclear ophthalmoparesis and ocular-motor fatigue in multiple sclerosis 57
WII may improve physical abilities in multiple sclerosis: a randomized single blind study 57
Pharmacoeconomics of synthetic therapies for multiple sclerosis 57
Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis 57
The efficacy of natalizumab and fingolimod on cognition in relapsing-remitting multiple sclerosis patients 56
Retinal thickness and microvascular pathway in Idiopathic Rapid eye movement sleep behaviour disorder and Parkinson's disease 56
Multiple Sclerosis, COVID-19 and Vaccines: Making the Point 56
Retinal Thickness in Essential Tremor and Early Parkinson Disease: Exploring Diagnostic Insights 55
Valutazione dell’efficacia clinica-batteriologica dell’ofloxacina e della levofloxacina nelle congiuntiviti batteriche 55
Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study 55
A dynamic interpretation of κFLC index for the diagnosis of multiple sclerosis: a change of perspective 54
Functional stress and alteration of the ocular surface in subjects video display terminal (VDT) 54
Microbiology synergism between tear substitutes and symbiotic treatment of patients with irritable bowel syndrome 54
Subclinical involvement of eye movements detected by video-based eye tracking in myasthenia gravis 53
Cilostazol reduces dry eye symptoms and improve walking distance in patients with peripheral artery disease 53
Factors driving delayed time to multiple sclerosis diagnosis: Results from a population-based study 53
Pharmacokinetic drug evaluation of daclizumab for the treatment of relapsing-remitting multiple sclerosis 53
Pain Following the Use of Anesthesia Formulation Among Individuals Undergoing Cataract Surgery: A Randomized Controlled Trial 53
Changes in John Cunningham Virus Index in Multiple Sclerosis Patients Treated with Different Disease-Modifying Therapies 52
Treatment in worsening multiple sclerosis patients: new drugs are better than older ones? 52
Pregnancy planning and management for women with multiple sclerosis: what has changed over the last 15 years? An Italian single-center experience 51
Prevalence and incidence of cognitive impairment in multiple sclerosis: a population-based survey in Catania, Sicily 51
The Cost-effectiveness of Sativex®: The Italian Experience Based on " in Resistant Multiple Sclerosis Spasticity: Discontinuation Study in a Large Population of Italian Patients, SA.FE. Study" 50
Aging with multiple sclerosis: prevalence and profile of cognitive impairment 49
Different patterns of acute saccadic response to levodopa in de novo Parkinson’s disease 49
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study 49
The mixture of bifidobacterium associated with fructooligosaccharides reduces the damage of the ocular surface 48
Rituximab for the treatment of multiple sclerosis: a review 48
Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study 47
Measurement Of Retinal Nerve Fibre Layer Thickness In Clinical Isolated Syndrome 47
Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience 47
Objective evaluation of Nintendo Wii Fit Plus balance program training on postural stability in Multiple Sclerosis patients: a pilot study 46
Hopelessness in Multiple Sclerosis: Psychological and Organic Correlates 45
Evolution of the concept of vascular dementia 45
Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series 44
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 43
Optic Nerve Head and Retinal Changes in Idiopathic Intracranial Hypertension: Correlation with Short-Term Cerebrospinal Fluid Pressure Monitoring 42
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients 42
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study 41
Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study) 40
Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: An Italian collaborative study 40
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry 39
Early reduction of retinal thickness predicts physical and cognitive disability in newly diagnosed multiple sclerosis patients: results from a cross-sectional study 39
Cognitive reserve is a determinant of social and occupational attainment in patients with pediatric and adult onset multiple sclerosis 39
Clinical and neurophysiological effects of fampridine in multiple sclerosis patients: a pilot study 38
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study 38
Long-term Cognitive Outcomes and Socioprofessional Attainment in People With Multiple Sclerosis With Childhood Onset 37
Totale 6.182
Categoria #
all - tutte 28.070
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.070


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021320 0 21 26 11 102 9 28 8 21 19 34 41
2021/2022595 54 93 13 22 90 4 88 18 18 4 19 172
2022/20231.281 87 90 29 138 100 196 16 269 282 12 50 12
2023/2024708 34 155 41 32 27 159 11 56 8 12 109 64
2024/20252.725 61 376 137 148 499 399 120 60 222 270 219 214
2025/2026660 393 267 0 0 0 0 0 0 0 0 0 0
Totale 6.885